We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+26.18%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$280B
AUM Growth
+$58B
Cap. Flow
-$9.91B
Cap. Flow %
-3.53%
Top 10 Hldgs %
32.38%
Holding
11,014
New
1,506
Increased
4,384
Reduced
3,586
Closed
1,324

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$861M
2
AAPL icon
Apple
AAPL
+$417M
3
JPM icon
JPMorgan Chase
JPM
+$350M
4
TMUS icon
T-Mobile US
TMUS
+$337M
5
AON icon
Aon
AON
+$296M

Sector Composition

Rank Sector Weight
1 Healthcare 3.54%
2 Technology 3.36%
3 Financials 2.95%
4 Consumer Discretionary 2.92%
5 Industrials 2.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XERS icon
8901
Xeris Biopharma Holdings
XERS
$1.57B
$86K ﹤0.01%
+32,388
New +$113K
CNR
8902
Core Natural Resources Inc
CNR
$4.76B
$86K ﹤0.01%
16,936
-70,781
-81% -$441K
TRQ
8903
CALL
DELISTED
Turquoise Hill Resources Ltd
TRQ
$86K ﹤0.01%
11,680
+6,080
+109% +$35.8K
MNOV icon
8904
CALL
MediciNova
MNOV
$64.5M
$85K ﹤0.01%
+15,700
New +$83.2K
WTTR icon
8905
Select Water Solutions
WTTR
$2.69B
$85K ﹤0.01%
17,295
-38,483
-69% -$176K
USX
8906
PUT
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$85K ﹤0.01%
14,100
+2,800
+25% +$12.8K
ACTG icon
8907
CALL
Acacia Research
ACTG
$448M
$84K ﹤0.01%
20,500
+8,600
+72% +$24.9K
CNDT icon
8908
CALL
Conduent
CNDT
$236M
$84K ﹤0.01%
35,200
-37,500
-52% -$87.2K
GNPX icon
8909
PUT
Genprex
GNPX
$2.18M
$84K ﹤0.01%
+1
New +$122K
INDP icon
8910
Indaptus Therapeutics
INDP
$143M
$84K ﹤0.01%
132
+78
+144% +$48.2K
MRNS
8911
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$84K ﹤0.01%
8,275
+2,100
+34% +$19.3K
BTG icon
8912
CALL
B2Gold
BTG
$6.79B
$83K ﹤0.01%
+14,500
New +$72.7K
CLIR icon
8913
CALL
ClearSign Technologies
CLIR
$31.7M
$83K ﹤0.01%
3,990
+140
+4% +$1.33K
OVID icon
8914
CALL
Ovid Therapeutics
OVID
$528M
$83K ﹤0.01%
+11,200
New +$52.4K
PACB icon
8915
PUT
Pacific Biosciences
PACB
$357M
$83K ﹤0.01%
24,100
+4,200
+21% +$14.3K
KA
8916
CALL
DELISTED
Kineta, Inc. Common Stock
KA
$83K ﹤0.01%
431
+49
+13% +$10K
CBAY
8917
CALL
DELISTED
Cymabay Therapeutics
CBAY
$83K ﹤0.01%
23,900
+6,500
+37% +$18.8K
NH
8918
PUT
DELISTED
NantHealth, Inc
NH
$83K ﹤0.01%
+1,207
New +$48.1K
CFRX
8919
DELISTED
ContraFect Corporation
CFRX
$83K ﹤0.01%
+162
New +$79.5K
BCS icon
8920
Barclays
BCS
$94.7B
$82K ﹤0.01%
14,571
-533,772
-97% -$2.78M
GEOS icon
8921
PUT
Geospace Technologies
GEOS
$72.4M
$82K ﹤0.01%
+10,900
New +$72.5K
MGY icon
8922
PUT
Magnolia Oil & Gas
MGY
$6.22B
$82K ﹤0.01%
+13,500
New +$73.7K
MUX icon
8923
CALL
McEwen Inc
MUX
$1.15B
$82K ﹤0.01%
8,100
+3,720
+85% +$34.5K
NNBR icon
8924
NN Inc
NNBR
$322M
$82K ﹤0.01%
17,281
-26,234
-60% -$91.6K
TRST
8925
Trustco Bank Corp NY
TRST
$977M
$82K ﹤0.01%
2,587
-9,529
-79% -$282K

Similar funds

Ken Griffin's Q2 2020 Portfolio in Review

As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.

  • Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
  • Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
  • Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
  • Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
  • Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
  • Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.

Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.